Search - tctmd.com

Displaying 101 - 120 of 147

Sort: Relevancy | Date

News Industry News

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

July 01, 2015

News Daily News

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Yael L. Maxwell

June 26, 2015

Presentation CCVVC 2015

Covered Stents in Femoropopliteal Disease

Presenter: Subhash Banerjee

June 18, 2015

Presentation CCVVC 2015

CFA: Endo or Open

Presenter: Carlos I. Mena

June 18, 2015

Presentation CCVVC 2015

Economics of Drug-Coated Technology in PAD

Presenter: Mark W. Burket

June 17, 2015

Presentation ARCH 2015

Below the Knee Stenting

Presenter: George S. Chrysant

April 10, 2015

Presentation

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

Presenter: G.Tepe

February 04, 2015

Presentation ISET 2015

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Presenter: Gunnar Tepe

February 02, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

Caitlin E. Cox

October 24, 2014

News Daily News

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

Caitlin E. Cox

October 24, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Presentation

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Presenter: Monika Herten

October 16, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation

Drug-Eluting Balloon in Peripheral Intervention for Below-the-Knee Angioplasty Evaluation

Presenter: Francesco Liistro

July 01, 2013

Advertisement

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Covered Stents in Femoropopliteal Disease

CFA: Endo or Open

Economics of Drug-Coated Technology in PAD

Below the Knee Stenting

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Drug-Eluting Balloon in Peripheral Intervention for Below-the-Knee Angioplasty Evaluation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content